99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours. - von Guggenberg, E.; Dietrich, H.; Skvortsova, I.; Gabriel, M.; Virgolini, I. J.; Decristoforo, C. (European Journal of Nuclear Medicine & Molecular Imaging, 2007)